Market News Video
Tags:
Monday, August 03, 2009
FDA Rejects KRYSTEXXA As A Treatment For Chronic Gout
Savient Pharmaceuticals (SVNT) announced that it has received a complete response letter from the U.S. Food and Drug Administration stating that the FDA cannot at this time approve the Company's application for KRYSTEXXA as a treatment for chronic gout in patients refractory to conventional therapy.
Market News Video
Market News Video
Subscribe to:
Post Comments (Atom)
LinkWithin
1 comment:
Try these alternative health practices, a way of staying healthy and fit. I have tried many ways but this one is something, I was inspired to create CYH (CreateYourHealth) as a way to empower you to take responsibility for your life. This site gives a lot of information regarding health alternative choices. You will enjoy everything about it, specially their topics about alternative health practices, vinyasa flow yoga, ear coning, prolotherapy, dynamic psychotherapy and neurofeedback. Check this site http://www.CreateYourHealth.com
Post a Comment